The Expanded Disability Status Scale (EDSS) and the Functional Systems Score (FSS) together describe severity of disability in patients with MS. With the help of the FSS, the examiner rates your disability on the EDSS scale. It ranges from 0 to 10, with half points for greater specificity. EDSS. • Expanded Disability Status Scale. – Devised by John Kurtzke in the s and modified A modification of the original Kurtzke scale.

Author: Gozuru Mazuzshura
Country: Paraguay
Language: English (Spanish)
Genre: Medical
Published (Last): 18 March 2008
Pages: 412
PDF File Size: 12.51 Mb
ePub File Size: 14.10 Mb
ISBN: 804-6-29293-507-8
Downloads: 98393
Price: Free* [*Free Regsitration Required]
Uploader: Goltijas

Expanded Disability Status Scale (EDSS)

Multiple sclerosis severity score: Clin Exp Immunol ; Requires two walking aids — pair of canes, crutches, etc — to walk about 20m without resting. The progressive disability in multiple sclerosis MS remains a therapeutic problem despite numerous medications available.

More recently, a new score was developed based on the initial EDSS score and the time of disease progression for each patient. Rating neurologic impairment in multiple sclerosis: Points assigned based on level of disability.

Expanded Disability Status Scale (EDSS) | MS Unites – Multiple Sclerosis (MS) Information Portal

Subcategory of ‘Diagnosis’ designed to be very sensitive Rule Out. Loss of bladder function. Abnormal signs without disability.


Essentially restricted to bed or chair or pushed in wheelchair. Up and about in wheelchair some 12 hours a day. STAT5 mediates antiapoptotic effects of methylprednisolone on oligodencrocytes.

To answer these questions will require studies correlating antibodies against interferon, the major histocompatibility complex and additional pharmacogenetic studies. Has some effective use of arms retains some self care functions.

J Neurol Neurosurg Psychiatry ; Glucocorticoid treatment restores the impaired suppressive function of regulatory T cells in patients with relapsing-remitting multiple sclerosis. N Engl J Med ; After the introduction of one type of medication, it was changed if the patient had two or more relapses per year and showed progression in disease disability an irreversible shewt more than one point in the EDSS over 6 months period or socre drug effects.

Disease-modifying therapy in MS: Rosana Herminia Scola received honoraria for consultation and speaking from Merck-Serono and research grant from Bayer-Schering.

The mechanism of action of methylprednisolone in the treatment of multiple sclerosis.

Can wheel self but can not carry on in standard wheelchair for sneet full day and may require a motorized wheelchair 8. J Manag Care Pharm ; Defining the clinical course of multiple sclerosis: Requires a walking aid — cane, crutch, etc — to walk about m with or without resting. Multiple Sclerosis MS Symptoms: Axonal transec tion in the lesions of multiple sclerosis.


Crit Rev Immunol ; All the patients received the same amount of medication despite the age, scoer, weight and disease duration Table 1.

Expanded Disability Status Scale (EDSS) / Functional Systems Score (FSS) – MDCalc

Gray matter pathology in chronic MS: Diagnostic criteria for multiple sclerosis: Retains many self-care functions. Restricted to wheelchair and may need aid in transferring. Mitoxantrone as induction treatment in aggressive relapsing multiple sclerosis: The efficacy of azathioprine in relapsing-remitting multiple sclerosis. Generally has effective use of arms.

Mild or moderate paraparesis or hemiparesis; severe monoparesis.